Cell surface polymer display in Gram-positive bacteria

革兰氏阳性菌细胞表面聚合物展示

基本信息

项目摘要

Project Summary Pathogenic bacteria display polymeric virulence factors to establish and maintain infections. We will investigate the mechanisms through which these polymers are produced and search for small molecule polymer assembly inhibitors. Two types of surface polymers in Gram-positive bacteria will be studied, (i) pili, proteinaceous fibers that project from the cell surface to mediate adhesion to host tissues, and (ii) Wall Teichoic Acids (WTAs), highly abundant glycopolymers that play a fundamental role in maintaining the integrity of the cell wall. Both pili and WTA polymers are important virulence factors, but how they are synthesized is poorly understood. In aims #1- 2, we will study how the archetypal SpaA-pilus from Corynebacterium diphtheria is assembled by sortase polymerases. These enzymes catalyze a unique transpeptidation reaction that covalently links adjacent protein pilus subunits together via a lysine isopeptide bond, thereby conferring enormous tensile strength that enables bacterial adherence. By synergistically employing structural, biochemical, cellular and chemical tools, we will learn how sortase polymerases build the pilus shaft and define the structure of the fundamental building block from which all Gram-positive pili are constructed. We will also determine the molecular basis through which pilus biogenesis is terminated via a novel handoff mechanism in which the pilus is transferred between tandemly arranged sortases on the cell surface. This work will have a broad impact, as a wide range of pathogenic microbes use a similar mechanism to assemble their pili. In aim #3, we will study how Gram-positive bacteria produce WTA using the TarA enzyme, a novel glycosyltransferase that catalyzes the first committed step in polymer biosynthesis. TarA is a promising drug target, as clinically relevant methicillin-resistant Staphylococcus aureus (MRSA) is defective in host colonization and re-sensitized to Beta-lactam drugs when WTA biosynthesis is disrupted. Crystal structures of TarA in its apo- and substrate-bound forms will be determined, facilitating the rational exploration of its catalytic mechanism. High-throughput screening using a novel, cell-based bacterial cytological profiling assay will also be performed to discover small molecule TarA inhibitors that could have useful therapeutic properties. Combined, studies of pilus and WTA biogenesis will provide fundamental insight into the chemistry underlying polymer assembly in Gram-positive bacteria and could lead to novel antibiotics to treat infections caused by MRSA and other multi-drug resistant bacteria.
项目摘要 病原菌显示聚合毒力因子以建立和维持感染。我们将调查 这些聚合物的生产机制和寻找小分子聚合物组装 抑制剂的革兰氏阳性菌的两种表面聚合物将被研究,(i)皮利,蛋白质纤维 从细胞表面突出以介导与宿主组织的粘附,和(ii)壁磷壁酸(WTA), 在维持细胞壁完整性方面发挥重要作用的丰富的糖聚合物。皮利和 WTA聚合物是重要的毒力因子,但它们是如何合成的知之甚少。目标#1- 2、我们将研究来自白喉棒杆菌的原型SpaA-pilus如何通过分选酶组装 聚合酶这些酶催化一种独特的转肽反应, 菌毛亚基通过赖氨酸异肽键结合在一起,从而赋予巨大的拉伸强度, 细菌粘附通过协同使用结构,生物化学,细胞和化学工具,我们将 了解分选酶聚合酶如何构建菌毛轴并定义基本构建块的结构 所有革兰氏阳性皮利都是由其构成的。我们还将确定菌毛 生物发生通过一种新的传递机制终止,在该机制中菌毛在串联的 在细胞表面排列分选酶。这项工作将产生广泛的影响,作为一个广泛的致病性 微生物使用类似的机制来组装它们的皮利。在目标#3中,我们将研究革兰氏阳性菌如何 使用塔拉酶生产WTA,这种酶是一种新型的糖基转移酶, 聚合物生物合成塔拉是一个有前途的药物靶点,因为临床上相关的耐甲氧西林葡萄球菌 金黄色葡萄球菌(MRSA)在宿主定植中有缺陷,当WTA生物合成时, 被打乱了将确定塔拉在其载脂蛋白和底物结合形式下的晶体结构,以促进 并对其催化机理进行了合理的探讨。使用一种新的基于细胞的细菌进行高通量筛选 还将进行细胞学谱分析以发现可能具有有用的生物学活性的小分子塔拉A抑制剂。 治疗特性。结合起来,菌毛和WTA生物发生的研究将提供基本的洞察力, 革兰氏阳性菌中聚合物组装的化学基础,并可能导致新的抗生素治疗 由MRSA和其他多重耐药细菌引起的感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Thompson Clubb其他文献

Robert Thompson Clubb的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Thompson Clubb', 18)}}的其他基金

Molecular basis of heme scavenging by Gram-positive bacteria
革兰氏阳性菌清除血红素的分子基础
  • 批准号:
    10330038
  • 财政年份:
    2021
  • 资助金额:
    $ 44.8万
  • 项目类别:
Bruker Avance III Console and QCI Cryoprobe for a 600 MHz NMR Spectrometer
用于 600 MHz NMR 波谱仪的 Bruker Avance III 控制台和 QCI 冷冻探针
  • 批准号:
    8640777
  • 财政年份:
    2014
  • 资助金额:
    $ 44.8万
  • 项目类别:
ITC: Isothermal Titration Calorimeter
ITC:等温滴定量热计
  • 批准号:
    8246922
  • 财政年份:
    2012
  • 资助金额:
    $ 44.8万
  • 项目类别:
Bruker 800 MHz TCI CryoProbe
布鲁克 800 MHz TCI CryoProbe
  • 批准号:
    7046272
  • 财政年份:
    2006
  • 资助金额:
    $ 44.8万
  • 项目类别:
BRUKER 800 MHZ TCI CRYOPROBE: STRUCTURE/FUNCTION OF HIV-1 VPR
布鲁克 800 MHZ TCI 冷冻探针:HIV-1 VPR 的结构/功能
  • 批准号:
    7335201
  • 财政年份:
    2006
  • 资助金额:
    $ 44.8万
  • 项目类别:
BRUKER 800 MHZ TCI CRYOPROBE: STRUCTURES AND DYNAMICS OF PROTEINS
BRUKER 800 MHZ TCI 冷冻探针:蛋白质的结构和动力学
  • 批准号:
    7335202
  • 财政年份:
    2006
  • 资助金额:
    $ 44.8万
  • 项目类别:
Cell Surface Protein Anchoring in Gram-positive Bacteria
革兰氏阳性细菌中的细胞表面蛋白锚定
  • 批准号:
    6888548
  • 财政年份:
    2002
  • 资助金额:
    $ 44.8万
  • 项目类别:
Cell Surface Protein Anchoring and Function in Gram-Positive Bacteria
革兰氏阳性细菌的细胞表面蛋白锚定和功能
  • 批准号:
    8437143
  • 财政年份:
    2002
  • 资助金额:
    $ 44.8万
  • 项目类别:
Cell Surface Protein Anchoring in Gram-Positive Bacteria
革兰氏阳性细菌中的细胞表面蛋白锚定
  • 批准号:
    7263369
  • 财政年份:
    2002
  • 资助金额:
    $ 44.8万
  • 项目类别:
Cell Surface Protein Anchoring in Gram-Positive Bacteria
革兰氏阳性细菌中的细胞表面蛋白锚定
  • 批准号:
    7767708
  • 财政年份:
    2002
  • 资助金额:
    $ 44.8万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.8万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.8万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.8万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 44.8万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 44.8万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 44.8万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 44.8万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 44.8万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 44.8万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 44.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了